Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 23, 2024, titled "New Drug Application of Zydus innovative drug Desidustat tablets by China Medical System Holdings Limited accepted in China".
Press Release Apr 23 2024
Filed with NSE · · 4 pages · English
Summary by 6ix AI
This development is expected to enhance the commercialization process of Desidustat in Greater China, according to the Managing Director of Zydus. Desidustat is marketed in India under the brand name Oxemia™ and is designed to improve treatment compliance for patients.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Apr 22 2024
- Press Release Apr 20 2024
- Press Release Apr 01 2024
- Press Release Mar 23 2024
- Press Release Mar 16 2024
Later from Zydus Lifesciences
- Press Release Apr 26 2024
- Press Release May 04 2024
- Press Release May 09 2024
- Press Release May 11 2024
- Zydus Lifesciences Limited Press Release May 17 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences